1. SAT0074 Selectively antagonizing the EP4 prostanoid receptor significantly ameliorates pathological features in a rat model for inflammatory arthritis. (23rd January 2014) Authors: Chiusaroli, R.; Ferrari, F.A.; Borriello, M.; Grotti, A.; Catapano, L.; Cavagnoli, R.; Lanza, M.; Stasi, L.P.; Rovati, L.; Caselli, G. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0066 CR6086, a Selective Antagonist at the EP4 Prostanoid Receptor, Improves or Resolves Disease Features in a RAT Model of Rheumatoid Arthritis. (9th June 2015) Authors: Chiusaroli, R.; Grotti, A.; Lanza, M.; Caselli, G.; Rovati, L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0067 CR6086, a Selective Antagonist at the EP4 Prostanoid Receptor, Improves or Resolves Disease Features in a Mouse Model of Rheumatoid Arthritis. (9th June 2015) Authors: Chiusaroli, R.; Cavagnoli, R.; Letari, O.; Lanza, M.; Caselli, G.; Rovati, L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗